Sequence Therapy with FOLFIRINOX and Gemcitabine/Nab-Paclitaxel for Patients with Advanced Pancreatic Cancer: A Monocentre Retrospective Cohort Study.
Saved in:
| Title: | Sequence Therapy with FOLFIRINOX and Gemcitabine/Nab-Paclitaxel for Patients with Advanced Pancreatic Cancer: A Monocentre Retrospective Cohort Study. |
|---|---|
| Authors: | Queck A; Department of Gastroenterology, Hepatology and Endocrinology, University Hospital Frankfurt, Frankfurt, Germany, Alexander.Queck@kgu.de., Elango S; Department of Gastroenterology, Hepatology and Endocrinology, University Hospital Frankfurt, Frankfurt, Germany., Koch C; Department of Gastroenterology, Hepatology and Endocrinology, University Hospital Frankfurt, Frankfurt, Germany.; University Cancer Center Frankfurt, Frankfurt, Germany., Walter D; Department of Gastroenterology, Hepatology and Endocrinology, University Hospital Frankfurt, Frankfurt, Germany.; University Cancer Center Frankfurt, Frankfurt, Germany., Schmidt J; Department of Gastroenterology, Hepatology and Endocrinology, University Hospital Frankfurt, Frankfurt, Germany.; University Cancer Center Frankfurt, Frankfurt, Germany., Trebicka J; Department of Gastroenterology, Hepatology and Endocrinology, University Hospital Frankfurt, Frankfurt, Germany., Trojan J; Department of Gastroenterology, Hepatology and Endocrinology, University Hospital Frankfurt, Frankfurt, Germany.; University Cancer Center Frankfurt, Frankfurt, Germany., Pession U; University Cancer Center Frankfurt, Frankfurt, Germany.; Department of General, Visceral and Transplant Surgery, University Hospital Frankfurt, Frankfurt, Germany., Finkelmeier F; Department of Gastroenterology, Hepatology and Endocrinology, University Hospital Frankfurt, Frankfurt, Germany.; University Cancer Center Frankfurt, Frankfurt, Germany., Waidmann O; Department of Gastroenterology, Hepatology and Endocrinology, University Hospital Frankfurt, Frankfurt, Germany.; University Cancer Center Frankfurt, Frankfurt, Germany. |
| Source: | Oncology research and treatment [Oncol Res Treat] 2022; Vol. 45 (3), pp. 79-87. Date of Electronic Publication: 2021 Dec 07. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: S. Karger Country of Publication: Switzerland NLM ID: 101627692 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2296-5262 (Electronic) Linking ISSN: 22965270 NLM ISO Abbreviation: Oncol Res Treat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2296-5262 |
|---|---|
| DOI: | 10.1159/000521258 |
